| 750468 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Acute kidney injury in patients treated with immune checkpoint inhibitors |
2021-10-01 |
10.1136/jitc-2021-003467 |
Gupta Shruti, Short Samuel A P, Sise Meghan E, Prosek Jason M, Madhavan Sethu M, Soler Maria Jose, Ostermann Marlies, Herrmann Sandra M, Abudayyeh Ala, Anand Shuchi, Glezerman Ilya, Motwani Shveta S, Murakami Naoka, Wanchoo Rimda, Ortiz-Melo David I, Rashidi Arash, Sprangers Ben, Aggarwal Vikram, Malik A Bilal, Loew Sebastian, Carlos Christopher A, Chang Wei-Ting, Beckerman Pazit, Mithani Zain, Shah Chintan V, Renaghan Amanda D, Seigneux Sophie De, Campedel Luca, Kitchlu Abhijat, Shin Daniel Sanghoon, Rangarajan Sunil, Deshpande Priya, Coppock Gaia, Eijgelsheim Mark, Seethapathy Harish, Lee Meghan D, Strohbehn Ian A, Owen Dwight H., Husain Marium, Garcia-Carro Clara, Bermejo Sheila, Lumlertgul Nuttha, Seylanova Nina, Flanders Lucy, Isik Busra, Mamlouk Omar, Lin Jamie S, Garcia Pablo, Kaghazchi Aydin, Khanin Yuriy, Kansal Sheru K, Wauters Els, Chandra Sunandana, Schmidt-Ott Kai M, Hsu Raymond K, Tio Maria C, Sarvode Mothi Suraj, Singh Harkarandeep, Schrag Deborah, Jhaveri Kenar D, Reynolds Kerry L, Cortazar Frank B, Leaf David E |
| 750467 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES) |
2021-10-01 |
10.1136/jitc-2021-002995 |
Lau Peter Kar Han, Feran Breon, Smith Lorey, Lasocki Arian, Molania Ramyar, Smith Kortnye, Weppler Alison, Angel Christopher, Kee Damien, Bhave Prachi, Lee Belinda, Young Richard J, Iravani Amir, Yeang Hanxian Aw, Vergara Ismael A, Kok David, Drummond Kate, Neeson Paul Joseph, Sheppard Karen E, Papenfuss Tony, Solomon Benjamin J, Sandhu Shahneen, McArthur Grant A |
| 750466 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting |
2021-10-01 |
10.1136/jitc-2020-001334corr1 |
|
| 750465 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity |
2021-10-01 |
10.1136/jitc-2020-001595corr1 |
|
| 750464 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer |
2021-10-01 |
10.1136/jitc-2020-002044corr1 |
|
| 750463 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany |
2021-10-01 |
10.1136/jitc-2020-001701corr1 |
|
| 750462 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity |
2021-10-01 |
10.1136/jitc-2020-001387corr1 |
|
| 750461 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch |
2021-10-01 |
10.1136/jitc-2020-001932corr1 |
|
| 750460 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer |
2021-10-01 |
10.1136/jitc-2020-002115corr1 |
|
| 750459 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma |
2021-10-01 |
10.1136/jitc-2021-002947 |
Deng Yuwei, Su Wenjia, Zhu Junwen, Ji Hongfei, Zhou Xiaoping, Geng Jingshu, Zhu Jiayu, Zhang Qingyuan |
